Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP001400) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
Centyrin anti-Fc-gamma-RII S29
|
|||||
| Synonyms |
Centyrin S29
|
|||||
| Molecular Weight | 10 kDa | |||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Expression System | Expi293F human cells | |||||
| Selection Method | CIS display | |||||
| Highest Status | Research | |||||
| Sequence Length | 89 | |||||
| Template Name | Antibody SF2 | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS020 | [1] | ||||
| Scaffold Name | Centyrin | |||||
| Scaffold Class | Non-Antibody | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Low affinity immunoglobulin gamma Fc region receptor II-a | Binder | Cancers [ICD-11: 2D4Z] | N.A. | Janssen Research & Development, L.L.C. | [1] | |